CAN-2409 Plus Valacyclovir Generates Positive Phase 2 Survival Results in PDAC

Positive phase 2 findings for CAN-2409 plus valacyclovir in pancreatic ductal adenocarcinoma have been reported.

Related Keywords

United States , Garrett Nichols , Candel Therapeutics Inc , Candel Therapeutics , Peter Tak ,